Anteo Diagnostics to Acquire Established Global Diagnostics Company DIAsource ImmunoAssays SA

26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty

Continue
CEO Activities Report – Quarter Ended 30 June 2015

The Company has been extremely busy in the period since our last report. This CEO Activities Report provides context and further information on the highlights of last quarter. In summary:

Continue
Van Leeuwenhoeck Research: Anteo Diagnostics – Emerging Leader in Nanotechnology

On July 13 2015, Van Leeuwenhoeck released their Research Note about Anteo Diagnostics. The highlights include: In the IVD market, Anteo is successfully implementing a strategy that has the ability

Continue
Josh Soldo, VP Scientific Affairs Presents at Beckman Coulter’s Knowledge Café

By invitation from Beckman Coulter, Anteo’s VP of Scientific Affairs, Josh Soldo, presented at their Knowledge Café on Wednesday 8 July to a great reception. Beckman’s Knowledge Café is an

Continue